📖 Approx. 5 min ／ Updated: 2026.08.16
In this article, an M&A advisor specializing in the healthcare industry provides a practical perspective on how converting to a Specified Medical Corporation becomes a key issue in business succession and healthcare M&A during due diligence. We outline specific measures based on audits of financial, legal, labor, and clinical practice aspects, as well as tax benefits and public interest requirements.
1. Industry Background of Due Diligence in Converting to a Specified Medical Corporation
According to the Dynamic Survey of Medical Care Institutions by the Ministry of Health, Labour and Welfare, the business environment for medical institutions, including due diligence aspects, has become increasingly challenging in recent years due to compound factors such as medical fee revisions, rising personnel costs, and the burden of capital expenditures. Interest in third-party succession M&A is growing, particularly from the perspective of auditing financial, legal, labor, and clinical operations.
At the same time, converting to a Specified Medical Corporation serves as an important consideration in healthcare M&A practice. By appropriately designing tax benefits and public interest requirements, a succession mutually beneficial to both the seller and buyer can be achieved.
2. Key Practical Points
- Advance Preparation: Organize business workflows, patient bases, and equipment status specific to due diligence, and clarify transfer conditions.
- Corporate Valuation: Calculate an appropriate transfer price range based on the characteristics of clinical departments. In due diligence, audits of financial, legal, labor, and clinical operations serve as key evaluation factors.
- Structuring Specified Medical Corporation Conversion: Select the optimal scheme taking into account tax incentives and public interest requirements. Verification from tax, legal, and labor perspectives is also required.
- Buyer Search & Matching: Select prospective buyers matching the characteristics of clinical specialties from a nationwide network. Carefully align desired conditions between parties.
- Due Diligence: Conduct thorough audits across financial, legal, labor, and clinical practice dimensions. Verify regulatory permits, licenses, and facility standards specific to due diligence.
- Definitive Agreement & Closing: Execute the final contract, including representations and warranties and indemnification clauses. Transfer permits and inform hospital/clinic staff in parallel.
3. Specific Considerations in Due Diligence
In medical institution M&A during due diligence, audits of financial, legal, labor, and clinical operations hold the key to a successful succession. Numerous individual issues arise depending on the clinical specialty, such as continuity of the patient base, retention of staff (physicians, nurses, allied health professionals), equipment condition and replacement plans, and maintenance or acquisition of facility standards.
Furthermore, designing a strategy based on market characteristics specific to due diligence—such as the ratio between insured and self-pay medical care, local healthcare collaboration status, and relationships with nearby competing medical institutions—is crucial. Leveraging our track record in succession support, we assist with practical operations from an industry-specialized perspective.
4. Practical Details of Converting to a Specified Medical Corporation
Converting to a Specified Medical Corporation is an area requiring specialized review in healthcare M&A. Structuring the process around tax benefits and public interest requirements is essential to success.
- Review of Relevant Laws and Practical Standards: Compliance and preparation based on the Medical Care Act, tax laws, and labor legislation
- Collaboration with Experts: Joint efforts with certified public accountants, tax accountants, attorneys, and labor/social security attorneys
- Risk Assessment: Identification of latent risks and formulation of mitigation policies
- Consensus Building Between Parties: Designing mutually acceptable terms for both seller and buyer
- Proper Documentation: Explicit inclusion in the Memorandum of Understanding (MOU) and definitive agreement
Frequently Asked Questions
Q. What documents are required for consultation?
A. Preparation in advance of financial statements for the last 3 fiscal years, patient volume trends, staffing structure, equipment list, lease agreements (if applicable), etc. ensures a smooth process. We accept these after executing a Non-Disclosure Agreement (NDA).
Q. What is the average valuation/transfer price range in due diligence cases?
A. Due diligence evaluates financial, legal, labor, and clinical practice aspects. As a benchmark, non-bed clinics are valued at 0.5 to 1.5 times annual revenue, while clinics with beds or hospitals range from 3 to 7 times EBITDA. Details can be provided through our free initial valuation.
Q. What points should be noted when proceeding with conversion to a Specified Medical Corporation?
A. Advance design incorporating tax incentives and public interest requirements is essential. Seamless practical execution in collaboration with experts holds the key to success.
Q. Will employees or patients find out about the consultation?
A. Information disclosure is strictly limited under NDA, and no disclosures are made to stakeholders prior to the final contract. Strict confidentiality is guaranteed.
Related Articles
- Complete Guide to Hospital & Medical Corporation M&A Business Succession
- Complete Overview of Clinic Sale & Transfer: Price Averages, Process, and Key Points
- How to Conduct Healthcare M&A & Hospital Succession | Timeline, Costs, and Key Points
- Tax Schemes in Medical Corporation M&A: Key Issues Experts Should Know
Contact M&A Medical for Consultations on Due Diligence & Converting to a Specified Medical Corporation
Strictly Confidential • Free Initial Consultation • Success Fee Basis